A tale of two antibodies: obinutuzumabversusrituximab-Reference-Cited by-同舟云学术

A tale of two antibodies: obinutuzumabversusrituximab

Published:2018-05-09 Issue:1 Volume:182 Page:29-45
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Freeman Ciara L.¹^ORCID,Sehn Laurie H.¹

Affiliation:

1. Centre for Lymphoid Cancer; British Columbia Cancer and the University of British Columbia; Vancouver BC Canada

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15232/fullpdf

Reference148 articles.

1. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma;Alas;Clinical Cancer Research,2002

2. Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies;Alduaij;Blood,2011

3. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia;Almasri;American Journal of Hematology,1992

4. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation;Anderson;Blood,1984

5. Which anti-CD20 antibody is better in follicular lymphoma?;Armitage;New England Journal of Medicine,2017

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of COVID-19 in patients with obinutuzumab compared with patients with rituximab: a retrospective cohort study;Virology Journal;2024-09-09

2. Therapeutic targets in membranous nephropathy: plasma cells and complement;Clinical Kidney Journal;2024-08-13

3. Obinutuzumab as Initial or Second-Line Therapy in Patients With Primary Membranous Nephropathy;Kidney International Reports;2024-08

4. Obinutuzumab in Refractory Membranous Nephropathy: A Case Series;Kidney Medicine;2024-08

5. Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemia;Leukemia Research;2024-08